Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.83.1.52PMID 1984898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Heart Failure

  2005cited by this paper
• Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial).

  1990cited by this paper
• The Interaction Between Diltiazem and Left Ventricular Function After Myocardial Infarction

  1989cited by this paper
• The effect of diltiazem on mortality and reinfarction after myocardial infarction.

  1989cited by this paper
• Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far.

  1987cited by this paper
• The effects of calcium-entry blockade on left ventricular systolic and diastolic function.

  1987cited by this paper
• A new electrocardiographic classification for post-myocardial infarction clinical trials.

  1987cited by this paper
• Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.

  1986cited by this paper
• Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.

  1986cited by this paper
• Left ventricular function before and after diltiazem in patients with coronary artery disease.

  1985cited by this paper
• Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study.

  1985cited by this paper
• Differential effects of diltiazem and nitroprusside on left ventricular function in experimental chronic volume overload.

  1983cited by this paper
• Clinical outcome after treatment of rest angina with calcium blockers: comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil.

  1983cited by this paper
• Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: report of a cooperative clinical trial.

  1982cited by this paper
• Hemodynamic Consequences of Combined Beta‐adrenergic and Slow Calcium Channel Blockade in Man

  1982cited by this paper
• Efficacy of diltiazem in angina on effort: a multicenter trial.

  1982cited by this paper
• Nifedipine and left ventricular function in beta-blocked patients.

  1981cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• Effects of calcium channel blockers on GDMT prescription and outcomes according to ejection fraction: IN-HF real world data.

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update

  2025cites this paper
• Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

  2025cites this paper
• Antiarrhythmic Drug Therapy for Acute Management of Atrial Fibrillation and Atrial Flutter.

  2025cites this paper
• 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Insights and Unresolved Questions.

  2025cites this paper
• Intravenous Verapamil for the Management of Atrial Fibrillation: The Gap Between the Guidelines and Clinical Practice

  2025cites this paper
• Integration of electrophysiological and mechanical biomarkers in cardiac risk assessment models

  2025cites this paper
• Clinical Outcomes Associated With Diltiazem Use in Heart Failure With Reduced Ejection Fraction After Implementation of a Clinical Support System

  2024cites this paper
• Heart Failure in Elderly Patients: Medical Management, Therapies and Biomarkers

  2024cites this paper
• Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management

  2024cites this paper
• [Principles of Outpatient Care of Patients With Heart Failure].

  2024cites this paper
• Practice Patterns of Rate Control In Atrial Fibrillation and Clinical Outcomes From A Nationwide Cohort.

  2024cites this paper
• When cardiovascular medicines should be discontinued.

  2024cites this paper
• Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction: New Assessment of an Old Problem.

  2024cites this paper
• Pathophysiology and treatment of adults with arrhythmias in the emergency department, part 1: Atrial arrhythmias.

  2023cites this paper
• Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure

  2023cites this paper
• Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure

  2023cites this paper
• Safety and Efficacy of Nondihydropyridine Calcium Channel Blockers for Acute Rate Control in Atrial Fibrillation with Rapid Ventricular Response and Comorbid Heart Failure with Reduced Ejection Fraction

  2023cites this paper
• Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study

  2023cites this paper
• 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• Un(b)locking therapeutic options: Potential for calcium channel blockers in heart failure with non‐reduced left ventricular ejection fraction

  2023cites this paper
• Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

  2023cites this paper
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2023cites this paper
• Polypill and Combination Therapy: Blood Pressure and Cardiovascular Risk Reduction

  2023cites this paper
• An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps

  2022cites this paper
• SGLT2 Inhibitors and Their Antiarrhythmic Properties

  2022influential citation
• Calcium dysregulation in heart diseases: targeting calcium channels to achieve a correct calcium homeostasis.

  2022cites this paper
• Mechanisms of current therapeutic strategies for heart failure: more questions than answers?

  2022cites this paper
• The impact of medical therapy on left ventricular strain: Current state and future perspectives

  2022cites this paper
• Hypocalcemic cardiomyopathy: A case report

  2022cites this paper
• Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica

  2022cites this paper
• Chinese expert consensus on the diagnosis and treatment of chronic heart failure in elderly patients (2021)

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

  2022cites this paper
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.

  2021cites this paper
• Current concept in the diagnosis, treatment and rehabilitation of patients with congestive heart failure

  2021cites this paper
• Intravenous Metoprolol Versus Diltiazem for Rate Control in Atrial Fibrillation

  2021cites this paper
• Fixed-dose combination amlodipine–celecoxib for treatment of hypertension and osteoarthritis pain: an up-to-date evaluation

  2021cites this paper
• Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

  2021cites this paper
• Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial Fibrillation.

  2021cites this paper
• Quality indicators for the care and outcomes of adults with atrial fibrillation.

  2020cites this paper
• Pharmacologic Management of Atrial Fibrillation and Flutter

  2020cites this paper
• Targeting Ca2 + Handling Proteins for the Treatment of Heart Failure and Arrhythmias

  2020cites this paper
• Management of Acute Heart Failure during an Early Phase

  2020cites this paper
• Five-Year Outcomes of Heart Failure with Preserved Ejection Fraction

  2020cites this paper
• Managing the elderly patient with hypertension: current strategies, challenges, and considerations

  2020cites this paper
• EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)

  2020cites this paper
• Approaches for the Management of Resistant Hypertension in 2020

  2020cites this paper
• ЛЕКАРСТВЕННО-ИНДУЦИРОВАННАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ (ЧАСТЬ 1: АКТУАЛЬНОСТЬ, РАСПРОСТРАНЕННОСТЬ, ПРИЧИНЫ)

  2020cites this paper
• Potentially harmful drug prescription in elderly patients with heart failure with reduced ejection fraction

  2020cites this paper
• Nanoscale regulation of L-type calcium channels differentiates between ischemic and dilated cardiomyopathies.

  2020cites this paper
• Redox-Active Drug, MnTE-2-PyP5+, Prevents and Treats Cardiac Arrhythmias Preserving Heart Contractile Function

  2020cites this paper
• Dysrhythmias and Hypertension

  2020cites this paper
• Cardioprotective Effects of Mebudipine in a Rat Model of Doxorubicin-Induced Heart Failure

  2020cites this paper
• Atrial fibrillation for internists: current practice.

  2020cites this paper
• Update on the Pharmacotherapy of Heart Failure with Reduced Ejection Fraction

  2020cites this paper
• Хроническая сердечная недостаточность. Клинические рекомендации 2020

  2020cites this paper
• Atrial arrhythmias in heart failure with a reduced ejection fraction.

  2020cites this paper
• Acute Decompensated Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction.

  2020cites this paper
• Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF).

  2020influential citation
• Managing Hypertension in the elderly: What’s new?

  2020cites this paper
• The Care of Patients with Atrial Fibrillation and Heart Failure.

  2020cites this paper
• Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions

  2020cites this paper
• Cardiac Disease in Older Adults

  2020cites this paper
• The Use of Calcium Channel Blockers in Heart Failure

  2019cites this paper
• Clarity and controversy around rate control in AF, the orphan child in AF therapeutics.

  2019cites this paper
• Heart Failure Council of Thailand (HFCT) 2019 Heart Failure Guideline: Comorbidity in Heart Failure

  2019cites this paper
• Implications of the new 2017 American College of Cardiology/American Aeart Association Guidelines for Hypertension.

  2019cites this paper
• Atrial Fibrillation in Heart Failure—Diagnostic, Therapeutic, and Prognostic Relevance

  2019cites this paper
• Calcium Channel Blockers Co-prescribed with Loop Diuretics: A Potential Marker of Poor Prescribing?

  2019cites this paper
• 2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations

  2019cites this paper
• Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent

  2019cites this paper
• Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis

  2019cites this paper
• Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.

  2019cites this paper
• JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.

  2019cites this paper
• Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia/reperfused isolated rat hearts.

  2019cites this paper
• 2019 Chinese guideline for the management of hypertension in the elderly

  2019cites this paper
• Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy

  2019cites this paper
• Beta Blockers and Calcium Channel Blockers

  2019cites this paper
• Evolving Targets for Heart Failure: the Journey so far

  2019cites this paper
• β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study

  2019cites this paper
• Antihypertensive drug therapy.

  2018cites this paper
• Implications of the New National Guidelines for Hypertension.

  2018cites this paper
• 2018 Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation

  2018cites this paper
• VII ) Enfermedad cardiovascular en el anciano

  2018cites this paper
• National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018.

  2018cites this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cites this paper
• Korean Heart Rhythm Society Guidelines for The Rate Control of Atrial Fibrillation

  2018cites this paper
• 2018 Korean Guideline of Atrial Fibrillation Management

  2018cites this paper